These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23339006)

  • 21. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
    Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
    Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
    Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
    Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy.
    Filosso PL; Öberg K; Malczewska A; Lewczuk A; Roffinella M; Aslanian H; Bodei L
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1195-1202. PubMed ID: 32047924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.
    Filosso PL; Guerrera F; Evangelista A; Welter S; Thomas P; Casado PM; Rendina EA; Venuta F; Ampollini L; Brunelli A; Stella F; Nosotti M; Raveglia F; Larocca V; Rena O; Margaritora S; Ardissone F; Travis WD; Sarkaria I; Sagan D;
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):441-7; discussion 447. PubMed ID: 25564217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship and expression of hepatocyte growth factor and vascular endothelial growth factor in serum preoperative and postoperative patients with laryngeal squamous cell cancer].
    Wang Y; Zhao H; Chen J; Liu L; Zhang P; Che J; Wang G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 24(24):1112-5. PubMed ID: 21395178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties.
    Soga J; Yakuwa Y
    Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):211-9. PubMed ID: 10508944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
    Hörsch D; Schmid KW; Anlauf M; Darwiche K; Denecke T; Baum RP; Spitzweg C; Grohé C; Presselt N; Stremmel C; Heigener DF; Serke M; Kegel T; Pavel M; Waller CF; Deppermann KM; Arnold R; Huber RM; Weber MM; Hoffmann H
    Oncol Res Treat; 2014; 37(5):266-76. PubMed ID: 24853787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic approach of carcinoid tumours of the lung.
    Ruggieri M; Scocchera F; Genderini M; Mascaro A; Paolini A
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):43-6. PubMed ID: 11409188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.
    Nilsson A; Janson ET; Eriksson B; Larsson A
    Anticancer Res; 2001; 21(6A):4087-90. PubMed ID: 11911297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgically treated bronchopulmonary carcinoid tumours. Prognostic value of TNM staging 7a edition].
    Patané AK; Poleri C; Martín C; Pupareli C; Rosales A; Rivero H; Rojas O; Rosenberg M
    Medicina (B Aires); 2014; 74(6):437-42. PubMed ID: 25555002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
    Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
    Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactivity of various peptides in typical and atypical bronchopulmonary carcinoid tumours.
    al-Saffar N; White A; Moore M; Hasleton PS
    Br J Cancer; 1988 Dec; 58(6):762-6. PubMed ID: 2906252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M; Ohta Y
    Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects.
    Wilander E; Lundqvist M; Oberg K
    Prog Histochem Cytochem; 1989; 19(2):1-88. PubMed ID: 2662260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinical study of resected bronchopulmonary carcinoids].
    Hayakawa M; Maeda H; Sawabata N; Funakoshi Y; Okumura Y
    Kyobu Geka; 2001 Aug; 54(9):769-72. PubMed ID: 11517547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
    Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
    J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.